COSCIENS Biopharma Inc. Adjustments For Unrealised Foreign Exchange Losses Gains
COSCIENS Biopharma Inc. (CSCIF) reported Adjustments For Unrealised Foreign Exchange Losses Gains of -$513.00 thousand for the 3-month period ending 2022-06-30, per its 6-K/A filed 2022-08-04.
Discontinued › Income Statement › Other Income
ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains · last filed 2022-11-03
- COSCIENS Biopharma Inc. adjustments for unrealised foreign exchange losses gains for the quarter ending 2022-06-30 was -$513.00K.
- COSCIENS Biopharma Inc. adjustments for unrealised foreign exchange losses gains for the quarter ending 2022-03-31 was -$174.00K, a 165.41% decline year-over-year.
- COSCIENS Biopharma Inc. adjustments for unrealised foreign exchange losses gains for the quarter ending 2021-12-31 was -$261.00K.
- COSCIENS Biopharma Inc. adjustments for unrealised foreign exchange losses gains for the quarter ending 2021-09-30 was -$45.00K.
| Period end | Adjustments For Unrealised Foreign Exchange Losses Gains 3 month | Adjustments For Unrealised Foreign Exchange Losses Gains 3 month as first filed | Adjustments For Unrealised Foreign Exchange Losses Gains 6 month | Adjustments For Unrealised Foreign Exchange Losses Gains 9 month | Adjustments For Unrealised Foreign Exchange Losses Gains 9 month as first filed | Adjustments For Unrealised Foreign Exchange Losses Gains 12 month |
|---|---|---|---|---|---|---|
| 2022-06-30 | -$513.00K 6-K/A · filed 2022-08-04 | -$687.00K 6-K/A · filed 2022-08-04 | -$948.00K derived: sum of 3 quarters · filed 2022-08-04 | -$993.00K derived: sum of 4 quarters · filed 2022-11-03 | ||
| 2022-03-31 | -$174.00K 6-K · filed 2022-05-11 | -$435.00K derived: sum of 2 quarters · filed 2022-05-11 | -$480.00K derived: sum of 3 quarters · filed 2022-11-03 | -$534.00K derived: sum of 4 quarters · filed 2022-11-03 | ||
| 2021-12-31 | -$261.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-29 | -$306.00K derived: sum of 2 quarters · filed 2022-11-03 | -$360.00K derived: sum of 3 quarters · filed 2022-11-03 | -$179.00K 20-F · filed 2022-03-29 | ||
| 2021-09-30 | -$45.00K 6-K · filed 2022-11-03 | -$111.00K 6-K · filed 2021-11-04 | -$99.00K derived: sum of 2 quarters · filed 2022-11-03 | $82.00K 6-K · filed 2022-11-03 | $101.00K 6-K · filed 2021-11-04 | -$226.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$54.00K 6-K/A · filed 2022-08-04 | $212.00K 6-K/A · filed 2022-08-04 | -$181.00K derived: sum of 3 quarters · filed 2022-08-04 | -$444.00K derived: sum of 4 quarters · filed 2022-08-04 | ||
| 2021-03-31 | $266.00K 6-K · filed 2022-05-11 | -$127.00K derived: sum of 2 quarters · filed 2022-05-11 | -$390.00K derived: sum of 3 quarters · filed 2022-05-11 | -$474.00K derived: sum of 4 quarters · filed 2022-05-11 | ||
| 2020-12-31 | -$393.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-29 | -$656.00K derived: sum of 2 quarters · filed 2022-03-29 | -$740.00K derived: sum of 3 quarters · filed 2022-03-29 | -$688.00K 20-F · filed 2022-03-29 | ||
| 2020-09-30 | -$263.00K 6-K · filed 2021-11-04 | -$347.00K derived: sum of 2 quarters · filed 2021-11-04 | -$295.00K 6-K · filed 2021-11-04 | -$321.00K derived: sum of 4 quarters · filed 2022-03-29 | ||
| 2020-06-30 | -$84.00K 6-K · filed 2021-08-05 | -$32.00K 6-K · filed 2021-08-05 | -$58.00K derived: sum of 3 quarters · filed 2022-03-29 | -$70.00K derived: sum of 4 quarters · filed 2022-03-29 | ||
| 2020-03-31 | $52.00K 6-K · filed 2021-05-05 | $26.00K derived: sum of 2 quarters · filed 2022-03-29 | $14.00K derived: sum of 3 quarters · filed 2022-03-29 | $10.00K derived: sum of 4 quarters · filed 2022-03-29 | ||
| 2019-12-31 | -$26.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-29 | -$38.00K derived: sum of 2 quarters · filed 2022-03-29 | -$42.00K derived: sum of 3 quarters · filed 2022-03-29 | -$87.00K 20-F · filed 2022-03-29 | ||
| 2019-09-30 | -$12.00K 6-K · filed 2020-11-05 | -$16.00K derived: sum of 2 quarters · filed 2020-11-05 | -$61.00K 6-K · filed 2020-11-05 | -$130.00K derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | -$4.00K 6-K · filed 2020-08-06 | -$49.00K 6-K · filed 2020-08-06 | -$118.00K derived: sum of 3 quarters · filed 2020-08-06 | $22.00K derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | -$45.00K 6-K/A · filed 2020-05-11 | -$114.00K derived: sum of 2 quarters · filed 2020-05-11 | $26.00K derived: sum of 3 quarters · filed 2020-05-11 | -$603.00K derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2018-12-31 | -$69.00K derived: 20-F 12 month − 6-K 9 month · filed 2020-03-31 | $71.00K derived: sum of 2 quarters · filed 2020-03-31 | -$558.00K derived: sum of 3 quarters · filed 2020-03-31 | -$652.00K 20-F · filed 2020-03-31 | ||
| 2018-09-30 | $140.00K 6-K · filed 2019-11-07 | -$489.00K derived: sum of 2 quarters · filed 2019-11-07 | -$583.00K 6-K · filed 2019-11-07 | |||
| 2018-06-30 | -$629.00K 6-K · filed 2019-08-13 | -$729.00K 6-K · filed 2019-08-13 | ||||
| 2017-12-31 | -$553.00K 20-F · filed 2020-03-31 | |||||
| 2016-12-31 | $87.00K 20-F · filed 2019-04-01 | |||||
| 2015-12-31 | $1.58M 20-F · filed 2018-03-28 |